P508Human umbilical cord blood-derived mesenchymal stem cells induce vascular endothelial growth in vivo

    loading  Checking for direct PDF access through Ovid



Stem cell therapies represent a hopeful option for cardiac regeneration. Here, we examined both the in vitro and in vivo acquisition of endothelial cell (EC)-specific lineage characteristics by umbilical cord blood-derived mesenchymal stem cells (UCBMSCs).


Cells were differentiated in the EC-specific growth medium EGM-2. Gene and protein expression were assessed by qRT-PCR, indirect immunofluorescence and Western blotting. In vitro vascular-like network formation was analyzed onto Matrigel. In vivo experiments using co-implantation of Matrigel and UCBMSCs modified for the expression of a human CD31 promoter-regulated luciferase reporter were also carried out in mice. Activation of CD31 promoter was monitored over time using non-invasive bioluminescence, and Matrigel plugs were removed for microvasculature growth analysis following fluorescent angiography. Differentiation response of modified UCBMSCs was finally examined in a mouse model of myocardial infarction (MI).


UCBMSC-derived ECs self organized into vascular-like networks in vitro. Co-implantation of Matrigel and modified UCBMSCs resulted in marked reporter and EC gene activation, and microcirculatory vessel formation as well. Cells embedded in a fibrin patch survived over the infarct area and developed CD31 + vascular-like structures 4 weeks post-implantation. MI-treated animals showed a reduced infarct scar and larger vessel occupied area in comparison with MI-control animals.


Our results show that UCBMSCs contribute to the formation of microcirculatory vessels in vivo, and promote revascularization of ischemic myocardium following acute infarction.

Related Topics

    loading  Loading Related Articles